1,998
Views
14
CrossRef citations to date
0
Altmetric
REVIEW

Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations

ORCID Icon, & ORCID Icon
Pages 281-295 | Published online: 04 Feb 2022

Figures & data

Figure 1 Personalized diabetes care. This figure summarizes the key considerations that are needed when contemplating the choice of diabetes pharmacotherapy for a patient with T2D.

Figure 1 Personalized diabetes care. This figure summarizes the key considerations that are needed when contemplating the choice of diabetes pharmacotherapy for a patient with T2D.

Figure 2 Therapeutic strategies for T2DM during time. This figure summarizes the key therapeutic strategies employed for people with T2D at different stages.

Abbreviations: IFG, impaired fasting glucose; IGT, impaired glucose tolerance; SGLT2i, sodium-glucose cotransporter-2 inhibitors; GLP-1RA, glucagon-like peptide-1 receptor analogue.
Figure 2 Therapeutic strategies for T2DM during time. This figure summarizes the key therapeutic strategies employed for people with T2D at different stages.

Table 1 Phenotypic Characteristics and Prevalence in the ANDIS (All New Diabetics in Scania) Cohort

Table 2 Summary of Type 2 Therapies: Effects on Cardiovascular Risk, Body Weight, Renal Use and Adverse Effects

Table 3 An Empirical View of Personalized Care for a Patient with T2DM